TY - JOUR
T1 - Melatonin til børn med søvnproblemer
AU - Berring-Uldum, Amalie
AU - Debes, Nanette Marinette Monique
AU - Pedersen, Charlotte Reinhardt
AU - Holst, Helle
PY - 2018
Y1 - 2018
N2 - Treatment for insomnia with melatonin (MT) in children and adolescents aged 0-17 years has doubled since 2011. The efficacy and safety profile for MT in children has not been determined. Recent clinical trials indicate, that MT only has a clinical effect on sleep latency, not on total sleep time. Furthermore, it has emerged, that proper sleep hygiene can cure the sleep problem in 50% of the children. Typically, the safety evaluation only entails an unclassified report of adverse events. Two long-term studies investigate and dispel the potential influence of MT on puberty.
AB - Treatment for insomnia with melatonin (MT) in children and adolescents aged 0-17 years has doubled since 2011. The efficacy and safety profile for MT in children has not been determined. Recent clinical trials indicate, that MT only has a clinical effect on sleep latency, not on total sleep time. Furthermore, it has emerged, that proper sleep hygiene can cure the sleep problem in 50% of the children. Typically, the safety evaluation only entails an unclassified report of adverse events. Two long-term studies investigate and dispel the potential influence of MT on puberty.
KW - Adolescent
KW - Central Nervous System Depressants/administration & dosage
KW - Child
KW - Child, Preschool
KW - Humans
KW - Melatonin/administration & dosage
KW - Puberty/drug effects
KW - Sleep/drug effects
KW - Sleep Hygiene
KW - Sleep Initiation and Maintenance Disorders/drug therapy
KW - Sleep Latency/drug effects
KW - Sleep Wake Disorders/drug therapy
M3 - Tidsskriftartikel
C2 - 29761771
SN - 0041-5782
VL - 180
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
IS - 19
M1 - V08170628
ER -